Self‑ monitoring for the prevention of diabetes complications

Česká verzia

Authors: R. Kožnarová
Authors place of work: Klinika diabetologie Centra diabetologie, Institut klinické a experimentální medicíny, Praha
Published in the journal: Kardiol Rev Int Med 2014, 16(2): 148-151
Category: Internal Medicine

Summary

Over the last few years, not only the number of patients with diabetes, but also the number of patients treated for late complications, has been rapidly increasing. One of the major factors contributing to their development is hyperglycaemia. An important part in preventing the complications is improved diabetes control. Self‑ monitoring plays an irreplaceable role in diabetes treatment. It involves measuring glucose levels and altering therapy according to the measured values. This paper summarizes the latest opinions on use of self‑ monitoring to improve diabetes control in patients with type 1 and type 2 diabetes and provides an overview of the current opportunities for applying technology in diabetology.

Keywords:
diabetes mellitus – late diabetes complications – self‑ monitoring – continuous glucose monitoring

Zdroje

1. Ústav zdravotnických informací a statistiky ČR [online]. Dostupné z: http:/ / www.uzis.cz

2. Cohen N, Shaw JE. Diabetes: advances in treatment. Intern Med J 2007; 37: 383– 388.

3. Kilpatrick ES, Rigby AS, Atkin SL. The effect of glucose variability on the long‑term risk of microvascular complications in type 1 diabetes. Diabetes Care 2006; 29: 1468– 1490.

4. Prázný M. Mikroangiopatie a diabetes mellitus. In: Perušičová J, Češka R et al (eds). KARDIABETES. Kardiovaskulární choroby a diabetes mellitus. Brno: Facta Medica 2009: 35– 47.

5. UK Prospective Diabetes Study Group. Intensive blood‑ glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patiens with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837– 853.

6. Gubitosi‑ Klug RA, DCCT/ EDIC Research Group. The diabetes control and complications trial/ epidemiology of diabetes interventions and complications study at 30 years: Summary and future directions. Diabetes Care 2014; 37; 44– 49. doi: 10.2337/ dc13– 2148.

7. The Diabetes Control and Complications Trial Group. The effect of intensive treatment of diabetes on development and progression of long‑term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977– 986.

8. Stettler C, Allemann S, Jüni P et al. Glycaemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta‑analysis of randomised trials. Am Heart J 2006; 152: 27– 38.

9. Janíčková‑ Žďárská D. Glykovaný hemoglobin a selfmonitoring glykemie – jejich využití a limitace. In: Kvapil M (ed). Diabetologie 2010. Praha: Triton 2010: 117– 131.

10. Mc Andrew L, Schneider SH, Burns E et al. Does patient blood glucose monitoring improve diabetes control? A systematic rewiew of the literature. Diabetes Educ 2007; 33: 991– 1011.

11. Martin S, Schneider B, Heinemann L et al. Self‑ monitoring of blood glucose in type 2 diabetes and long‑term outcome: an epidemiological cohort study. Diabetologia 2006; 49: 271– 278.

12. Welschen LM. Bloemendal E, Nijpels et al. Self‑ monitoring of blood glucose in patiens with type 2 diabetes who are not using insulin: a systematic rewiew. Diabetes Care 2005; 28: 1510– 1517.

13. Freckmann G, Schmid C, Baumstark A et al. System accuracy evaluation of 43 blood glucose monitoring systems for self‑ monitoring of blood glucose according to DIN EN ISO 15197. J Diabetes Sci Technol 2012; 6: 1060– 1075.

14. Fineberg SE, Bergenstal RM, Bernstein RM et al. Use of an automatic device for alternative site blood glucose monitoring. Diabetes Care 2001; 24: 1217– 1220.

15. JDRF Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, Bode BW et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008; 359: 1464– 1476. doi: 10.1056/ NEJMoa0805017.

16. Joubert M, Reznik Y. Personal continuous glucose monitoring (CGM) in diabetes management: rewiew of the litrature and implementation for practical use. Diabetes Res Clin Pract 2012; 96: 294– 305. doi: 10.1016/ j.diabres.2011.12.010.

17. Brož J. Kontinuální monitoring glykémie: přehled přístrojů, indikace, efektivita a přesnost metody. In: Rušavý Z et al (ed). Technologie v diabetologii. Praha: Galén 2010: 142– 152.

18. Kožnarová R. Novinky v monitoraci glykemie. Remedia 2012; 22: 72– 76.

19. Jirkovská A. Základní zásady kontinuální monitorace glykemie – pomohou nám v kompenzaci diabetu? Kazuistiky v diabetologii 2011; 4: 4– 8.

20. Deiss D, Bolinder J, Riveline JP et al. Improved glycemic control in poorly controlled patients with type 1 diabetes using real‑ time continuous glucose monitoring. Diabetes Care 2006; 29: 2730– 2732.

21. Garg S, Zisser H, Schwartz S et al. Improvement in glycaemic excursions with a transcutaneous, real‑ time continuous glucose sensor: a randomized controlled trial. Diabetes Care 2006; 29: 44– 50.

22. Bailey TS, Zisser HC, Garg SK. Reduction in hemoglobin A1C with real‑ time continuous glucose monitoring: results from a 12‑week observational study. Diabetes Technol Ther 2007; 9: 203– 210.

23. Maia FF, Araújo LR. Efficacy of continuous glucose monitoring system (CGMS) to detect postprandial hyperglycemia and unrecognized hypoglycemia in type 1 diabetic patients. Diabetes Res Clin Pract 2007; 75: 30– 34.

24. Wentholt IM, Maran A, Masurel N et al. Nocturnal hypoglycaemia in Type 1 diabetic patients, assessed with continuous glucose monitoring: frequency, duration and associations. Diabet Med 2007; 24: 527– 532.

25. Battelino T, Philip M, Bratina N et al. Effect of continuous glucose monitoring on hypoglycaemia in type 1 diabetes. Diabetes Care 2011; 34: 795– 800. doi: 10.2337/ dc10– 1989.

26. Bode B, Gross K, Rikalo N et al. Alarms based on real‑ time sensor glucose values alert patients to hypo‑ and hyperglycaemia: the guardian continuous monitoring system. Diabetes Technol Ther 2004; 6: 105– 113.

27. Gilliam LK, Hirsch IB. Practical aspects of real‑ time continuous glucose monitoring. Diabetes Technol Ther 2009; 11 (Suppl 1): S75– S82. doi: 10.1089/ dia.2008.0135.

28. Kožnarová R, Saudek F, Sosna T et al. Beneficial effect of pancreas and kidney transplantation on advanced diabetic retinopathy. Cell Transplant 2000; 9: 903– 908.